SafeBridge Consultants, Inc. Announces “Potent Compound Safety Certification” Approval for Baxter Oncology GmbH Facilities in Halle and Bielefeld, Germany
June 12, 2012
SAFEBRIDGE® CONSULTANTS, INC. ("SafeBridge"), headquartered in Mountain View, California, has announced that Baxter Oncology GmbH ("Baxter Oncology") in Westfalen, Germany has met the criteria established under the SafeBridge program for "Potent Compound Safety Certification" at their sterile fill/finish facility in Halle and at their API manufacturing facility in Bielefled. Both facilities have been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients (“APIs”). The SafeBridge Certification was achieved for the specific manufacturing and support areas related to manufacture and handling of carcinogenic, mutagenic and reproductive (“CMR”) products. Baxter Oncology becomes the first company in Europe to achieve SafeBridge Certification in potent compound sterile fill/finish production. The facilities in Halle and Bielefeld support Baxter’s BioPharma Solutions business, a contract manufacturing organization that partners with pharmaceutical companies to support their commercialization objectives. For more information please go to the following website.
SAFEBRIDGE CONSULTANTS, INC. is the premier occupational health and safety consulting firm to the pharmaceutical, biotechnology and fine chemical industry with offices in Mountain View, CA, New York, NY and Liverpool, UK. SafeBridge has provided the Potent Compound Safety Triangle™ of services in industrial hygiene, occupational toxicology and industrial hygiene analytical chemistry to over 500 business units worldwide and is a leader in recognizing, evaluating and controlling exposures to potent active pharmaceutical ingredients and products.
If you would like more information about SafeBridge please contact:
John P. Farris, CIH
President and Chief Executive Officer
650-961-4820 x 229